Children’s Hospital Resumes FDA-Funded Study Of PEG 3350 Pediatric Risks
Executive Summary
New FDA assays may show whether polyethylene glycol laxative leaves toxic analytes and metabolites in children with chronic constipation – with potential implications for numerous other products.
You may also be interested in...
FDA Global Supply Chain Concerns Prompt Glycerin DEG Testing Guidance
Pharmaceutical manufacturing facilities and compounding pharmacists should include tests for diethylene glycol content in the identity testing of all lots of glycerin they receive, according to an FDA guidance reflecting growing concern about vulnerabilities in the global supply chain
Forty-Eight US FDA Drug Application Decisions Delayed By Pandemic's Deferred Inspections
US FDA 'resilience' report charts how inspection backlog grew and impacted approvals and compliance follow-up.
World’s Pharmaceutical Inspectorates Prepare For Post-Pandemic Remote Site Assessments
US, EU, global authorities share experiences, insights, advice for industry on remote alternatives even after inspectors can resume travels.